Forbes December 25, 2020
Verily announced late last week that it just completed a fresh investment round and has raised nearly $700 million in funding from prominent investors. The funding comes at a time when the healthcare and life-sciences industries are facing multiple stressors, especially in the context of Covid-19 and the transforming landscape of clinical medicine.
Verily is a cutting-edge organization with a broad vision. Its interests include spearheading life-sciences research, innovation in healthcare delivery, and harnessing technology and digital tools to improve health outcomes and patient care, just to name a few.
According to the press release, “The capital will be used to support rapid expansion of some of Verily’s leading commercial businesses. These include Baseline, an end-to-end ecosystem designed to make...
Today's Sponsors
Today's Sponsor